Hollings Clinical Trials

Hollings Clinical Trials
Developer: The Medical University
Add to Compare
50 installs
1.00 ratings
1.00 monthly active users
Revenue not available

Hollings Clinical Trials Summary

Hollings Clinical Trials is a free iOS app in Medical by The Medical University of South Carolina. Released in May 2022 (4 years ago). It has 1.00 ratings with a 5.00★ (excellent) average. Based on AppGoblin estimates, it reaches roughly 1.00 monthly active users . Store last updated Sep 5, 2026

Hollings Clinical Trials SDKs Summary

App not yet scanned for SDKs.


5★

Ratings: 1.00

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot
App screenshot
App screenshot

App Description

This application is designed for patients, caregivers, healthcare providers, and research staff seeking information about cancer clinical trials available at the Medical University of South Carolina (MUSC) Hollings Cancer Center (HCC) and participating sites within the MUSC NCI Community Oncology Research Program for Minority and Underserved (NCORP-MU). Clinical trials are research studies that evaluate new approaches to cancer prevention, diagnosis, treatment, survivorship, and supportive care.

This application is organized into cancer treatment, cancer prevention, and supportive oncology clinical trials. Cancer treatment trials can be explored by disease group, helping users find studies that may be relevant to their specific cancer type. Users can explore actively enrolling clinical trials through an enhanced search experience designed to help identify studies that may be a good fit. Trial listings include patient-friendly titles, summaries, keywords, study details, and contact information. MUSC employees with a MUSC Net ID can also access study documents such as protocols and informed consent forms.

Users may click on the NCT link to connect to the CT.gov webpage and find the current trial eligibility criteria. All users can submit a contact request for help, and an employee of the Hollings Cancer Center Clinical Trials Office will respond.